Cargando…

159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis

Detalles Bibliográficos
Autores principales:	Kremer, T., Onge, I. St, Trivedi, M., Dy, F., Bielick, C., Fish, D., Schaefer, O., Longtine, J., Longtine, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518456/ http://dx.doi.org/10.1016/S1569-1993(21)01584-8

Ejemplares similares

156: Pre-procedural Sars-CoV-2 testing and pulmonary function testing
por: Onge, I. St, et al.
Publicado: (2021)

A multicenter randomized controlled clinical trial comparing central venous catheters impregnated with either 5-fluorouracil or chlorhexidine/silver sulfadiazine in preventing catheter colonization
por: Walz, JM, et al.
Publicado: (2008)

485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease
por: Hawkins, P., et al.
Publicado: (2022)

P135 SARS-COV-2 infection in patients with cystic fibrosis
por: Balanetchi, L., et al.
Publicado: (2021)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry
por: Rees, H., et al.
Publicado: (2021)

CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis
por: Martin, AC, et al.
Publicado: (2005)

P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2022)

25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis
por: Hergenroeder, G., et al.
Publicado: (2021)

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

Role of the Yeast Gin4p Protein Kinase in Septin Assembly and the Relationship between Septin Assembly and Septin Function
por: Longtine, Mark S., et al.
Publicado: (1998)

385 Mechanisms by which cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection
por: Tedbury, P., et al.
Publicado: (2022)

509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis
por: Bezzerri, V., et al.
Publicado: (2022)

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
por: McClenaghan, E., et al.
Publicado: (2021)

27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers
por: Hudock, K., et al.
Publicado: (2022)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

343: Impact of the SARS-CoV-2 pandemic and a food pantry on food insecurity in a pediatric cystic fibrosis center
por: Holzum, H., et al.
Publicado: (2021)

P095 Effect of age and genotype on lung function in children with cystic fibrosis
por: Shadrina, V., et al.
Publicado: (2021)

439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

P137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort
por: Steinack, C., et al.
Publicado: (2021)

P02.159. EEG asymmetry, coherence, and temperament in children
por: Wang, Y, et al.
Publicado: (2012)

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

A82 PREVALENCE AND NON-INVASIVE SCREENING FOR CYSTIC FIBROSIS RELATED LIVER DISEASE IN A COHORT FOLLOWED AT A CYSTIC FIBROSIS REFERENCE CENTER
por: Coman, D E, et al.
Publicado: (2023)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team
por: Jones, S., et al.
Publicado: (2021)

P146 COVID-19 pandemic in the Belgian cystic fibrosis patients compared with the international cystic fibrosis patients and the general Belgian population
por: Daneau, G., et al.
Publicado: (2023)

ARDS IN CYSTIC FIBROSIS PATIENT WITH DOUBLE LUNG TRANSPLANT SURVIVES SARS-COV-2
por: Modugula, Sujith, et al.
Publicado: (2020)

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021)

433 Differential small ribonucleic acid expression analysis reveals transforming growth factor beta role in SARS-CoV-2 infection of the cystic fibrosis airway
por: Hejenkowska, E., et al.
Publicado: (2022)

P231 Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England
por: Sanderson-Thomas, A., et al.
Publicado: (2021)

Assessing Shared Decision-Making in Cystic Fibrosis Care Using collaboRATE: A Cross-Sectional Study of 159 Programs
por: Homa, Karen, et al.
Publicado: (2021)

159. A Novel Framework to Guide Antibiotic Stewardship Nursing Practice
por: Manning, Mary Lou, et al.
Publicado: (2020)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

Caspase-mediated apoptosis of trophoblasts in term human placental villi is restricted to cytotrophoblasts and absent from the multinucleated syncytiotrophoblast
por: Longtine, Mark S, et al.
Publicado: (2012)

666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle
por: Mukherjee, A., et al.
Publicado: (2022)

418: Linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
por: Pitcher, N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uobh5naf5p6mg52b88hko55arj